Gary M Abrams, MD
Neurology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · University of California San Francisco · 1,780 clinicians in this group
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Abrams’s office at (415) 476-4029 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G81653 · Current
Licensed to practise in California · since 1995 · expires 2027-06-30 · University of Pittsburgh School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$6,716
Medicare paid this office $6,716 for 41 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 21 | $3,100 | $124 |
| New patient visit (60+ min) | 12 | $1,769 | $147 |
| Return visit (30+ min) | 17 | $1,519 | $69 |
Who their Medicare patients are
41 Original Medicare patients in 2024. Average age 67 · Under 65 27% · Women 49% · Also on Medicaid 29% · Health risk score 1.17. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 39% · Depression 37%.
The office billed $47,098, Medicare allowed $9,279 and paid $6,716; for 68 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 41 | 68 | 67 | 1.17 | $47,098 | $6,716 |
| 2023 | 34 | 44 | 67 | 1.33 | $33,511 | $4,543 |
| 2022 | 32 | 51 | 69 | 1.17 | $30,436 | $4,432 |
| 2021 | 28 | 43 | 68 | 1.04 | $29,996 | $4,072 |
| 2020 | 31 | 38 | 66 | 1.39 | $24,432 | $2,936 |
| 2019 | 39 | 45 | 67 | 1.25 | $33,997 | $3,928 |
| 2018 | 44 | 52 | 71 | 1.66 | $37,334 | $4,682 |
| 2017 | 41 | 77 | 66 | 1.50 | $42,595 | $6,033 |
| 2016 | 86 | 156 | 69 | 1.31 | $89,303 | $12,461 |
| 2015 | 63 | 133 | 67 | 1.17 | $79,020 | $10,395 |
| 2014 | 65 | 206 | 64 | 1.53 | $125,658 | $15,323 |
| 2013 | 82 | 187 | 66 | 1.54 | $108,303 | $14,429 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| New patient visit (60+ min) | 14 | $2,053 | $147 |
| Long return visit (40+ min) | 11 | $1,300 | $118 |
2022: 1 service
| New patient visit (60+ min) | 12 | $1,788 | $149 |
2020: 1 service
| Return visit (30+ min) | 14 | $997 | $62 |
2019: 2 services
| Return visit (30+ min) | 15 | $1,096 | $58 |
| Long return visit (40+ min) | 11 | $1,000 | $91 |
2018: 3 services
| New patient visit (60+ min) | 12 | $1,554 | $130 |
| Long return visit (40+ min) | 12 | $1,010 | $84 |
| Return visit (30+ min) | 13 | $839 | $60 |
2017: 2 services
| Long return visit (40+ min) | 14 | $1,590 | $99 |
| Return visit (30+ min) | 12 | $1,000 | $63 |
2016: 4 services
| Long return visit (40+ min) | 38 | $4,295 | $91 |
| Extended office or other outpatient service, first hour | 21 | $1,886 | $82 |
| Return visit (30+ min) | 22 | $1,699 | $61 |
| Short return visit (20+ min) | 15 | $768 | $40 |
2015: 4 services
| Long return visit (40+ min) | 24 | $2,730 | $94 |
| Return visit (30+ min) | 30 | $2,513 | $64 |
| New patient visit (60+ min) | 12 | $1,418 | $118 |
| Extended office or other outpatient service, first hour | 11 | $1,167 | $83 |
2014: 4 services
| Long return visit (40+ min) | 37 | $6,051 | $93 |
| Extended office or other outpatient service, first hour | 18 | $2,197 | $81 |
| Return visit (30+ min) | 20 | $1,735 | $60 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 12 | $1,396 | $42 |
2013: 4 services
| Long return visit (40+ min) | 33 | $4,590 | $94 |
| New patient visit (60+ min) | 17 | $2,360 | $139 |
| Return visit (30+ min) | 28 | $2,204 | $55 |
| Extended office or other outpatient service, first hour | 16 | $2,164 | $80 |
Drugs they prescribed that Part D paid
$13,548
Pharmacies billed $13,548 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 90) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
80 generic and fewer than 11 brand-name prescriptions · $13,548 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Methylphenidate | 11 | $196 | $18 |
| Diazepam | 12 | $47 | $4 |
Year by year
| 2024 | 90 | 19 | 0% (0) | None | $13,548 |
| 2023 | 87 | 13 | 0% (0) | None | $8,507 |
| 2022 | 86 | 14 | 0% (0) | None | $10,361 |
| 2021 | 64 | 13 | 0% (0) | 0% | $3,415 |
| 2020 | 44 | 12 | 0% (0) | None | $3,090 |
| 2019 | 61 | 11 | 0% (0) | None | $8,192 |
| 2018 | 79 | 15 | 0% (0) | None | $6,611 |
| 2017 | 111 | 13 | None | None | $5,200 |
| 2016 | 95 | 20 | None | None | $6,226 |
| 2015 | 87 | 18 | 0% (0) | None | $4,600 |
| 2014 | 108 | 18 | None | 10% | $4,757 |
| 2013 | 145 | 20 | None | 11% | $8,100 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Methylphenidate | 16 | $478 | $30 |
2022: 1 drug
| Methylphenidate | 23 | $741 | $32 |
2021: 1 drug
| Methylphenidate | 16 | $451 | $28 |
2018: 1 drug
| Gabapentin | 13 | $360 | $28 |
2017: 4 drugs
| Propranolol Hcl Er | 13 | $831 | $64 |
| Amantadine | 11 | $547 | $50 |
| Gabapentin | 16 | $305 | $19 |
| Verapamil | 11 | $55 | $5 |
2016: 3 drugs
| Baclofen | 14 | $725 | $52 |
| Gabapentin | 19 | $503 | $26 |
| Verapamil Er | 12 | $121 | $10 |
2015: 4 drugs
| Baclofen | 21 | $479 | $23 |
| Levetiracetam | 12 | $433 | $36 |
| Gabapentin | 12 | $356 | $30 |
| Verapamil Er | 13 | $135 | $10 |
2014: 3 drugs
| Levetiracetam | 17 | $532 | $31 |
| Gabapentin | 15 | $499 | $33 |
| Diazepam | 11 | $76 | $7 |
2013: 7 drugs
| Carbidopa-Levodopa | 15 | $561 | $37 |
| Escitalopram | 13 | $514 | $40 |
| Levetiracetam | 12 | $415 | $35 |
| Oxybutynin Chloride | 12 | $409 | $34 |
| Gabapentin | 14 | $328 | $23 |
| Baclofen | 12 | $172 | $14 |
| Lorazepam | 13 | $82 | $6 |
Money from drug and device companies
$74 in 2023
| 2023 | 1 | 2 | None | $74 |
| 2022 | 1 | 1 | None | $26 |
| 2020 | 1 | 1 | $2,040 | $2,040 |
| 2019 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Sogroya | $74 | 2 payments
|
See all 2 published payments
| Novo Nordisk | Education · 2023-09-13 | None | $32 |
| Novo Nordisk | Meals · 2023-09-08 | Sogroya | $41 |
See earlier years (2022, 2020, 2019)
2022: $26
| Novo Nordisk | Macrilen | $26 | 1 payment
|
2020: $2,040
| Novo Nordisk | Norditropin | $2,040 | 1 payment
|
2019: $25
| Novo Nordisk | Macrilen | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1346213246
- Licence
- CA G81653California G81653: Current · expires 2027-06-30
- Trained
- Perelman School of Med at the University of Pennsylvania, 1974
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X)
- Mailing address
- Po Box 942895, Sacramento, CA, 94295
- NPI first listed
- 2006-02-10
- NPI last updated
- 2012-08-20
This is when the NPI record was last certified, not a medical board exam.